Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

The FDA has approved Takeda’s new immunoglobulin therapy, Gammagard liquid ERC [immune globulin infusion (human)], to treat ...

This week, two major food recalls have caught the attention of consumers, including that of a Kilwins chocolate. FDA stresses ...

They’re a summer flavor favorite, and this is the first time we've seen a recall specifically for this controversial reason.

We need a complete reset of local government where citizens and residents fully participate in setting their local development agenda, determine spending priorities, eagerly pay their fair share of ...

A food recall of nearly 6,000 cases of cookies distributed across 15 states has been given the U.S. Food and Drug ...

The FDA has approved a new drug for sight-robbing disease geographic atrophy from Astellas, just a few weeks after the company bought its developer Iveric Bio for $5.9 billion.

Takeda Pharmaceuticals said the Food and Drug Administration approved its liquid Gammagard immunoglobulin treatment. The drugmaker said Monday that commercialization of Gammagard Liquid is expected to ...

Gammagard Liquid ERC is a ready-to-use formulation with low IgA content designed to ease administration burden by removing the need to reconstitute.

Some common dietary supplements can increase blood pressure, especially if you have high blood pressure or heart problems ...

The FDA has expanded existing warnings on the two leading COVID-19 vaccines about a rare heart side effect mainly seen in young men.